Literature DB >> 2468734

The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.

F Ceci1, C Cangiano, M Cairella, A Cascino, M Del Ben, M Muscaritoli, L Sibilia, F Rossi Fanelli.   

Abstract

Nineteen obese female subjects with body mass index ranging between 30 and 40 were included in a double-blind crossover study aimed at evaluating the effects of oral 5-hydroxytryptophan administration on feeding behavior, mood state and weight loss. Either 5-hydroxytryptophan (8 mg/kg/day) or placebo was administered for five weeks during which patients were not prescribed any dietary restrictions. Feeding behavior was investigated by means of a questionnaire designed to establish the onset of anorexia and related symptoms. Food intake was evaluated using a three-day diet diary. BDI, SI, STAI-T, and STAI-S were used to assess mood state. The administration of 5-hydroxytryptophan resulted in no changes in mood state but promoted typical anorexia-related symptoms, decreased food intake and weight loss during the period of observation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468734     DOI: 10.1007/bf01578751

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  12 in total

1.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

Review 2.  Role of precursor availability in control of monoamine biosynthesis in brain.

Authors:  J D Fernstrom
Journal:  Physiol Rev       Date:  1983-04       Impact factor: 37.312

3.  The effect of 5-hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine.

Authors:  J E Blundell; M B Leshem
Journal:  J Pharm Pharmacol       Date:  1975-01       Impact factor: 3.765

4.  Brain tryptophan and the neoplastic anorexia-cachexia syndrome.

Authors:  R Krause; J H James; V Ziparo; J E Fischer
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

5.  Precursor control of neurotransmitter synthesis.

Authors:  R J Wurtman; F Hefti; E Melamed
Journal:  Pharmacol Rev       Date:  1980-12       Impact factor: 25.468

6.  Changes in mood after carbohydrate consumption among obese individuals.

Authors:  H R Lieberman; J J Wurtman; B Chew
Journal:  Am J Clin Nutr       Date:  1986-12       Impact factor: 7.045

7.  Paraventricular nucleus: a primary site mediating adrenergic stimulation of feeding and drinking.

Authors:  S F Leibowitz
Journal:  Pharmacol Biochem Behav       Date:  1978-02       Impact factor: 3.533

8.  Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study.

Authors:  G Chouinard; S N Young; L Annable; T L Sourkes
Journal:  Acta Psychiatr Scand       Date:  1979-04       Impact factor: 6.392

9.  Plasma tryptophan and anorexia in human cancer.

Authors:  F Rossi Fanelli; C Cangiano; F Ceci; R Cellerino; F Franchi; E T Menichetti; M Muscaritoli; A Cascino
Journal:  Eur J Cancer Clin Oncol       Date:  1986-01

10.  Brain serotonin content: increase following ingestion of carbohydrate diet.

Authors:  J D Fernstrom; R J Wurtman
Journal:  Science       Date:  1971-12-03       Impact factor: 47.728

View more
  8 in total

1.  Plasma and CSF tryptophan in cancer anorexia.

Authors:  C Cangiano; A Cascino; F Ceci; A Laviano; M Mulieri; M Muscaritoli; F Rossi-Fanelli
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.

Authors:  Tisha Joy; Grace Walsh; Sonya Tokmakejian; Stan Hm Van Uum
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

3.  Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.

Authors:  P Ernsberger; R J Koletsky; L A Collins; D Bedol
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

Review 4.  Pharmacological targeting of the serotonergic system for the treatment of obesity.

Authors:  Alastair S Garfield; Lora K Heisler
Journal:  J Physiol       Date:  2008-11-24       Impact factor: 5.182

5.  Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administration.

Authors:  M Rondanelli; A Opizzi; M Faliva; M Bucci; S Perna
Journal:  Eat Weight Disord       Date:  2011-12-05       Impact factor: 3.008

6.  Preliminary fMRI findings concerning the influence of 5-HTP on food selection.

Authors:  Stephanos Ioannou; Adrian L Williams
Journal:  Brain Behav       Date:  2016-10-28       Impact factor: 2.708

Review 7.  Advances in the Microbial Synthesis of 5-Hydroxytryptophan.

Authors:  Xin-Xin Liu; Bin Zhang; Lian-Zhong Ai
Journal:  Front Bioeng Biotechnol       Date:  2021-02-03

8.  The effects of 5-hydroxytryptophan in combination with different Fatty acids on gastrointestinal functions: a pilot experiment.

Authors:  Helene Sauer; Isabelle Mack; Silke Kohler; Stefanie Siegle; Nicole Rieber; Stephan Zipfel; Bärbel Otto; Yvonne Ritze; Stephan C Bischoff; Paul Enck
Journal:  Gastroenterol Res Pract       Date:  2014-08-19       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.